HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Role of splenectomy in Chediak-Higashi syndrome in its accelerated phase].

Abstract
Chediak-Higashi (C.H.S.) syndrome is a rare immunodeficiency, due to defective granulocyte activity. The syndrome is characterized by large inclusion bodies in the leukocytes, albinism, photophobia, nystagmus, and recurrent infections. Some patients develop hepatosplenomegaly, lymphadenopathy, pancytopenia and widespread organ infiltrates with mononucleated cells. This phase is called "accelerated (or lymphoma-like syndrome) phase". A 5 years old girl with C.H.S. in accelerated phase received initially medical treatment without improvement. A splenectomy was performed to remove the hypersplenism and the mechanical compression of the spleen on the gut. Few days after the splenectomy the fever and the pancytopenia disappeared. The pathological examination of the spleen showed multiple intraparenchymal abscesses. Unfortunately, six months after the operation, she died after an acute episode of pneumonia, with normal hematological pattern. The splenectomy may play a role in the "accelerated phase" of C.H.S., but new treatments (bone marrow transplantation) are necessary to remove the basic disease.
AuthorsC Ammaturo, C Giardiello, R Pascotto, A Correra, N Tontoli, A Pelliccia, R V De Masi, P Micheli
JournalLa Pediatria medica e chirurgica : Medical and surgical pediatrics (Pediatr Med Chir) 1985 Jul-Aug Vol. 7 Issue 4 Pg. 593-7 ISSN: 0391-5387 [Print] Italy
Vernacular TitleRuolo della splenectomia nella sindrome di Chediak-Higashi (SCH) in fase accelerata.
PMID3837224 (Publication Type: Case Reports, English Abstract, Journal Article)
Topics
  • Chediak-Higashi Syndrome (pathology, surgery)
  • Child
  • Female
  • Humans
  • Splenectomy
  • Splenomegaly (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: